OFFBEAT MAIL

LOS ANGELES, Dec. 7, 2012 --Dr. Rongxiang Xu, the founder of "human body regenerative restoration science" and a renowned life scientist and medical scientist, has filed a lawsuit today against The Nobel Assembly at Karolinska Institutet, a Swedish corporation, aka, Nobelforsamlingen. The Nobel Assembly at Karolinska Institutet is a body which awards the Nobel Prize in Physiology or Medicine. The suit filed in Superior Court of the State of California, Orange County Central Justice Center cites Libel and unfair competition. Dr. Xu, one of the leading scientists in the world, discovered in 1984 the existence of "regenerative cell" which was confirmed to be keratin-19 positive stem cell after 2000 (US patent 6991813B2), during his study of burn treatments that has benefited 20 million burn victims in 73 countries, claims his good reputation in the community was defamed by a statement published by defendants, The Nobel Assembly, causing damages to Dr. Xu by their...

Increased restrictions on funding of stem cell research in the United States has forced many Americans to seek international medical treatment for their various ailments in developing countries. According to a website www.placidway.com : "The potential cost of stem cell therapies in the U.S. may be prohibitive expense, which encourages those hoping and seeking cures for illnesses, injuries and disease ;processes to travel to China, Thailand, Japan, Europe, and India, among others." The website said the cost of therapies is determined according to geographic location of treatment facilities as well as the injury, illness or disease being treated. "Because such treatments have not yet been approved in the U.S., medical travelers are cautioned to do their homework and study human stem cell therapy, treatments and protocols and examine the history as well as case studies in foreign destinations." To date, the U.S. has approved funding for Phase I clinical trials ...